Recombinant multi-species SNURF protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SNURF protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is located within the Prader-Willi Syndrome critical region on chromosome 15. Transcripts produced from this gene initiate at an imprinting center and are paternally-imprinted. These transcripts may be bicistronic and also encode SNRPN (small nuclear ribonucleoprotein polypeptide N) from a downstream open reading frame. The small protein represented by this gene is encoded by an evolutionarily-conserved upstream open reading frame and is localized to the nucleus. Extensive alternative splicing and promoter usage occurs in this region and the full-length nature of some of these transcripts has not been determined. Alterations in the imprinting center are associated with parental imprint switch failure, which may cause Angelman syndrome or Prader-Willi syndrome. [provided by RefSeq, Mar 2017]
The Alternative Names of target: 2410045I01Rik,SNRPN upstream reading frame protein,SNURF,Snurf

Target products collectionGo to SNURF products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP13329-Ag-1/ GM-Tg-hg-IP13329-Ag-2 Human SNURF protein Human
GM-Tg-rg-IP13329-Ag-1/ GM-Tg-rg-IP13329-Ag-2 Rat SNURF protein Rat
GM-Tg-mg-IP13329-Ag-1/ GM-Tg-mg-IP13329-Ag-2 Mouse SNURF protein Mouse
GM-Tg-cynog-IP13329-Ag-1/ GM-Tg-cynog-IP13329-Ag-2 Cynomolgus/Rhesus macaque SNURF protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP13329-Ag-1/ GM-Tg-felg-IP13329-Ag-2 Feline SNURF protein Feline
GM-Tg-cang-IP13329-Ag-1/ GM-Tg-cang-IP13329-Ag-2 Canine SNURF protein Canine
GM-Tg-bovg-IP13329-Ag-1/ GM-Tg-bovg-IP13329-Ag-2 Bovine SNURF protein Bovine
GM-Tg-equg-IP13329-Ag-1/ GM-Tg-equg-IP13329-Ag-2 Equine SNURF protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP13329-Ag-1/ GM-Tg-hg-IP13329-Ag-2; GM-Tg-rg-IP13329-Ag-1/ GM-Tg-rg-IP13329-Ag-2;
GM-Tg-mg-IP13329-Ag-1/ GM-Tg-mg-IP13329-Ag-2; GM-Tg-cynog-IP13329-Ag-1/ GM-Tg-cynog-IP13329-Ag-2;
GM-Tg-felg-IP13329-Ag-1/ GM-Tg-felg-IP13329-Ag-2; GM-Tg-cang-IP13329-Ag-1/ GM-Tg-cang-IP13329-Ag-2;
GM-Tg-bovg-IP13329-Ag-1/ GM-Tg-bovg-IP13329-Ag-2; GM-Tg-equg-IP13329-Ag-1/ GM-Tg-equg-IP13329-Ag-2
Products Name SNURF protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SNURF
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SNURF protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.